 | • レポートコード：MR6994NT6009 • 出版社/出版日：LP Information / 2026年7月 • レポート形態：英語、PDF、150ページ • 納品方法：Eメール（納期：3日） • 産業分類：製薬 |
| Single User（1名様閲覧用） | ￥570,960 (USD3,660) | ▷ お問い合わせ |
| Multi User（10名様閲覧用） | ￥856,440 (USD5,490) | ▷ お問い合わせ |
| Corporate User（閲覧人数無制限） | ￥1,141,920 (USD7,320) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界の低分子化学医薬品CDMO市場規模は、2025年の62,690百万米ドルから2032年には140,430百万米ドルへと拡大すると予測されており、2026年から2032年にかけて年平均成長率（CAGR）12.4％で成長すると見込まれています。 低分子化学医薬品の開発および製造には通常、多くの複雑な工程が伴い、その合成・製造には専門的な設備と技術が必要となります。CDMO（受託開発・製造機関）は、製薬企業にアウトソーシングサービスを提供する組織であり、医薬品の開発から製造に至るまで幅広いサービスを提供することができます。 米国の低分子化学医薬品CDMO市場は、2025年のUS$ millionから2032年にはUS$ millionへと拡大し、2026年から2032年にかけて年平均成長率（CAGR）％で成長すると推定されています。 中国の低分子化学医薬品CDMO市場は、2025年のUS$ millionから2032年までにUS$ millionへと拡大し、2026年から2032年までのCAGRは%になると推定されています。 欧州の低分子化学医薬品CDMO市場は、2025年のUS$ millionから2032年にはUS$ millionへと拡大し、2026年から2032年までのCAGRは%になると推定されています。 世界の主要な低分子化学医薬品CDMO企業には、Haixiang Pharmaceutical、Innovent Biologics、Betta Pharmaceuticals、Jiuzhou Pharmaceutical、Puluo Pharmaceuticalなどが含まれます。売上高の面では、2025年に世界トップ2社が市場シェアのほぼ％を占めた。 「低分子化学医薬品CDMO業界予測」では、過去の売上高を検証し、2025年の世界の低分子化学医薬品CDMO総売上高を分析するとともに、2026年から2032年までの低分子化学医薬品CDMO売上高予測について、地域および市場セクター別の包括的な分析を提供している。本レポートでは、低分子化学医薬品CDMOの売上高を地域、市場セクター、およびサブセクター別に分類し、世界の低分子化学医薬品CDMO業界について、単位：百万米ドルでの詳細な分析を提供しています。 本インサイトレポートは、世界の低分子化学医薬品CDMO業界の全体像を包括的に分析し、製品セグメンテーション、企業設立、売上高、市場シェア、最新動向、およびM&A活動に関連する主要なトレンドを明らかにしています。また、本レポートでは、低分子化学医薬品CDMOのポートフォリオと能力、市場参入戦略、市場での位置づけ、および地理的展開に焦点を当て、世界的な低分子化学医薬品CDMO市場の加速する動向の中で、主要グローバル企業の独自の立場をより深く理解できるよう、各社の戦略を分析しています。 本インサイトレポートでは、低分子化学医薬品CDMOの世界的な見通しを形作る主要な市場動向、推進要因、および影響要因を評価し、種類別、用途別、地域別、市場規模別に予測を細分化することで、新興の機会領域を浮き彫りにしています。数百件に及ぶボトムアップ型の定性・定量的な市場データに基づく透明性の高い方法論により、本調査の予測は、世界の低分子化学医薬品CDMO市場の現状と将来の推移について、極めて精緻な見解を提供します。 本レポートでは、製品タイプ、用途、主要企業、および主要地域・国別に、低分子化学医薬品CDMO市場の包括的な概要、市場シェア、成長機会を提示しています。 タイプ別セグメンテーション： ヒト用医薬品 動物用医薬品 用途別セグメンテーション： 臨床段階のプロジェクト 商業化段階のプロジェクト また、本レポートでは地域別に市場を分類しています： 南北アメリカ 米国 カナダ メキシコ ブラジル アジア太平洋地域（APAC） 中国 日本 韓国 東南アジア インド オーストラリア 欧州 ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下に紹介する企業は、主要な専門家からの情報および各企業の事業範囲、製品ポートフォリオ、市場浸透度を分析した上で選定されています。 Haixiang Pharmaceutical Innovent Biologics Betta Pharmaceuticals Jiuzhou Pharmaceutical Puluo Pharmaceutical Menohua Tianyu shares Aoxiang Pharmaceutical Hetero CellMark R&D Systems Porton Pharmaceuticals Kai Laiying Smart Life Notai Biotech Aurobindo Pharma Lonza Group Catalent Inc. Recipharm AB Jubilant Pharmova Ltd Patheon Inc. (Thermo Fisher Scientific Inc.) Boehringer Ingelheim Group Pfizer CentreSource Baxter International Inc. |
The global Small Molecule Chemical Drug CDMO market size is predicted to grow from US$ 62690 million in 2025 to US$ 140430 million in 2032; it is expected to grow at a CAGR of 12.4% from 2026 to 2032.
The development and production of small molecule chemical drugs usually involves many complex steps, and the synthesis and production of small molecule chemical drugs require specialized equipment and technology. CDMO (Contract Development and Manufacturing Organization) is an organization that provides outsourcing services to pharmaceutical companies. It can provide a range of services from drug development to production.
United States market for Small Molecule Chemical Drug CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Small Molecule Chemical Drug CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Small Molecule Chemical Drug CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Small Molecule Chemical Drug CDMO players cover Haixiang Pharmaceutical, Innovent Biologics, Betta Pharmaceuticals, Jiuzhou Pharmaceutical, Puluo Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
The “Small Molecule Chemical Drug CDMO Industry Forecast” looks at past sales and reviews total world Small Molecule Chemical Drug CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Molecule Chemical Drug CDMO sales for 2026 through 2032. With Small Molecule Chemical Drug CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Chemical Drug CDMO industry.
This Insight Report provides a comprehensive analysis of the global Small Molecule Chemical Drug CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Chemical Drug CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Chemical Drug CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Chemical Drug CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Chemical Drug CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Chemical Drug CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
Human Medicine
Veterinary Medicine
Segmentation by Application:
Clinical Stage Projects
Commercialization Stage Projects
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Haixiang Pharmaceutical
Innovent Biologics
Betta Pharmaceuticals
Jiuzhou Pharmaceutical
Puluo Pharmaceutical
Menohua
Tianyu shares
Aoxiang Pharmaceutical
Hetero
CellMark
R&D Systems
Porton Pharmaceuticals
Kai Laiying
Smart Life
Notai Biotech
Aurobindo Pharma
Lonza Group
Catalent Inc.
Recipharm AB
Jubilant Pharmova Ltd
Patheon Inc. (Thermo Fisher Scientific Inc.)
Boehringer Ingelheim Group
Pfizer CentreSource
Baxter International Inc.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule Chemical Drug CDMO Market Size (2021-2032)
2.1.2 Small Molecule Chemical Drug CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Small Molecule Chemical Drug CDMO by Country/Region (2021, 2025 & 2032)
2.2 Small Molecule Chemical Drug CDMO Segment by Type
2.2.1 Human Medicine
2.2.2 Veterinary Medicine
2.2.3 Small Molecule Chemical Drug CDMO Market Size by Type
2.2.3.1 Small Molecule Chemical Drug CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Small Molecule Chemical Drug CDMO Market Size Market Share by Type (2021-2026)
2.3 Small Molecule Chemical Drug CDMO Segment by Application
2.3.1 Clinical Stage Projects
2.3.2 Commercialization Stage Projects
2.3.3 Small Molecule Chemical Drug CDMO Market Size by Application
2.3.3.1 Small Molecule Chemical Drug CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Small Molecule Chemical Drug CDMO Market Size Market Share by Application (2021-2026)
3 Small Molecule Chemical Drug CDMO Market Size by Player
3.1 Small Molecule Chemical Drug CDMO Market Size Market Share by Player
3.1.1 Global Small Molecule Chemical Drug CDMO Revenue by Player (2021-2026)
3.1.2 Global Small Molecule Chemical Drug CDMO Revenue Market Share by Player (2021-2026)
3.2 Global Small Molecule Chemical Drug CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule Chemical Drug CDMO by Region
4.1 Small Molecule Chemical Drug CDMO Market Size by Region (2021-2026)
4.2 Global Small Molecule Chemical Drug CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas Small Molecule Chemical Drug CDMO Market Size Growth (2021-2026)
4.4 APAC Small Molecule Chemical Drug CDMO Market Size Growth (2021-2026)
4.5 Europe Small Molecule Chemical Drug CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size Growth (2021-2026)
5 Americas
5.1 Americas Small Molecule Chemical Drug CDMO Market Size by Country (2021-2026)
5.2 Americas Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026)
5.3 Americas Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule Chemical Drug CDMO Market Size by Region (2021-2026)
6.2 APAC Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026)
6.3 APAC Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule Chemical Drug CDMO Market Size by Country (2021-2026)
7.2 Europe Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026)
7.3 Europe Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule Chemical Drug CDMO by Region (2021-2026)
8.2 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule Chemical Drug CDMO Market Forecast
10.1 Global Small Molecule Chemical Drug CDMO Forecast by Region (2027-2032)
10.1.1 Global Small Molecule Chemical Drug CDMO Forecast by Region (2027-2032)
10.1.2 Americas Small Molecule Chemical Drug CDMO Forecast
10.1.3 APAC Small Molecule Chemical Drug CDMO Forecast
10.1.4 Europe Small Molecule Chemical Drug CDMO Forecast
10.1.5 Middle East & Africa Small Molecule Chemical Drug CDMO Forecast
10.2 Americas Small Molecule Chemical Drug CDMO Forecast by Country (2027-2032)
10.2.1 United States Market Small Molecule Chemical Drug CDMO Forecast
10.2.2 Canada Market Small Molecule Chemical Drug CDMO Forecast
10.2.3 Mexico Market Small Molecule Chemical Drug CDMO Forecast
10.2.4 Brazil Market Small Molecule Chemical Drug CDMO Forecast
10.3 APAC Small Molecule Chemical Drug CDMO Forecast by Region (2027-2032)
10.3.1 China Small Molecule Chemical Drug CDMO Market Forecast
10.3.2 Japan Market Small Molecule Chemical Drug CDMO Forecast
10.3.3 Korea Market Small Molecule Chemical Drug CDMO Forecast
10.3.4 Southeast Asia Market Small Molecule Chemical Drug CDMO Forecast
10.3.5 India Market Small Molecule Chemical Drug CDMO Forecast
10.3.6 Australia Market Small Molecule Chemical Drug CDMO Forecast
10.4 Europe Small Molecule Chemical Drug CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market Small Molecule Chemical Drug CDMO Forecast
10.4.2 France Market Small Molecule Chemical Drug CDMO Forecast
10.4.3 UK Market Small Molecule Chemical Drug CDMO Forecast
10.4.4 Italy Market Small Molecule Chemical Drug CDMO Forecast
10.4.5 Russia Market Small Molecule Chemical Drug CDMO Forecast
10.5 Middle East & Africa Small Molecule Chemical Drug CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market Small Molecule Chemical Drug CDMO Forecast
10.5.2 South Africa Market Small Molecule Chemical Drug CDMO Forecast
10.5.3 Israel Market Small Molecule Chemical Drug CDMO Forecast
10.5.4 Turkey Market Small Molecule Chemical Drug CDMO Forecast
10.6 Global Small Molecule Chemical Drug CDMO Forecast by Type (2027-2032)
10.7 Global Small Molecule Chemical Drug CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Small Molecule Chemical Drug CDMO Forecast
11 Key Players Analysis
11.1 Haixiang Pharmaceutical
11.1.1 Haixiang Pharmaceutical Company Information
11.1.2 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
11.1.3 Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Haixiang Pharmaceutical Main Business Overview
11.1.5 Haixiang Pharmaceutical Latest Developments
11.2 Innovent Biologics
11.2.1 Innovent Biologics Company Information
11.2.2 Innovent Biologics Small Molecule Chemical Drug CDMO Product Offered
11.2.3 Innovent Biologics Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Innovent Biologics Main Business Overview
11.2.5 Innovent Biologics Latest Developments
11.3 Betta Pharmaceuticals
11.3.1 Betta Pharmaceuticals Company Information
11.3.2 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product Offered
11.3.3 Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Betta Pharmaceuticals Main Business Overview
11.3.5 Betta Pharmaceuticals Latest Developments
11.4 Jiuzhou Pharmaceutical
11.4.1 Jiuzhou Pharmaceutical Company Information
11.4.2 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
11.4.3 Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Jiuzhou Pharmaceutical Main Business Overview
11.4.5 Jiuzhou Pharmaceutical Latest Developments
11.5 Puluo Pharmaceutical
11.5.1 Puluo Pharmaceutical Company Information
11.5.2 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
11.5.3 Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Puluo Pharmaceutical Main Business Overview
11.5.5 Puluo Pharmaceutical Latest Developments
11.6 Menohua
11.6.1 Menohua Company Information
11.6.2 Menohua Small Molecule Chemical Drug CDMO Product Offered
11.6.3 Menohua Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Menohua Main Business Overview
11.6.5 Menohua Latest Developments
11.7 Tianyu shares
11.7.1 Tianyu shares Company Information
11.7.2 Tianyu shares Small Molecule Chemical Drug CDMO Product Offered
11.7.3 Tianyu shares Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Tianyu shares Main Business Overview
11.7.5 Tianyu shares Latest Developments
11.8 Aoxiang Pharmaceutical
11.8.1 Aoxiang Pharmaceutical Company Information
11.8.2 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
11.8.3 Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Aoxiang Pharmaceutical Main Business Overview
11.8.5 Aoxiang Pharmaceutical Latest Developments
11.9 Hetero
11.9.1 Hetero Company Information
11.9.2 Hetero Small Molecule Chemical Drug CDMO Product Offered
11.9.3 Hetero Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Hetero Main Business Overview
11.9.5 Hetero Latest Developments
11.10 CellMark
11.10.1 CellMark Company Information
11.10.2 CellMark Small Molecule Chemical Drug CDMO Product Offered
11.10.3 CellMark Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 CellMark Main Business Overview
11.10.5 CellMark Latest Developments
11.11 R&D Systems
11.11.1 R&D Systems Company Information
11.11.2 R&D Systems Small Molecule Chemical Drug CDMO Product Offered
11.11.3 R&D Systems Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 R&D Systems Main Business Overview
11.11.5 R&D Systems Latest Developments
11.12 Porton Pharmaceuticals
11.12.1 Porton Pharmaceuticals Company Information
11.12.2 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product Offered
11.12.3 Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Porton Pharmaceuticals Main Business Overview
11.12.5 Porton Pharmaceuticals Latest Developments
11.13 Kai Laiying
11.13.1 Kai Laiying Company Information
11.13.2 Kai Laiying Small Molecule Chemical Drug CDMO Product Offered
11.13.3 Kai Laiying Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Kai Laiying Main Business Overview
11.13.5 Kai Laiying Latest Developments
11.14 Smart Life
11.14.1 Smart Life Company Information
11.14.2 Smart Life Small Molecule Chemical Drug CDMO Product Offered
11.14.3 Smart Life Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Smart Life Main Business Overview
11.14.5 Smart Life Latest Developments
11.15 Notai Biotech
11.15.1 Notai Biotech Company Information
11.15.2 Notai Biotech Small Molecule Chemical Drug CDMO Product Offered
11.15.3 Notai Biotech Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Notai Biotech Main Business Overview
11.15.5 Notai Biotech Latest Developments
11.16 Aurobindo Pharma
11.16.1 Aurobindo Pharma Company Information
11.16.2 Aurobindo Pharma Small Molecule Chemical Drug CDMO Product Offered
11.16.3 Aurobindo Pharma Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Aurobindo Pharma Main Business Overview
11.16.5 Aurobindo Pharma Latest Developments
11.17 Lonza Group
11.17.1 Lonza Group Company Information
11.17.2 Lonza Group Small Molecule Chemical Drug CDMO Product Offered
11.17.3 Lonza Group Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Lonza Group Main Business Overview
11.17.5 Lonza Group Latest Developments
11.18 Catalent Inc.
11.18.1 Catalent Inc. Company Information
11.18.2 Catalent Inc. Small Molecule Chemical Drug CDMO Product Offered
11.18.3 Catalent Inc. Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Catalent Inc. Main Business Overview
11.18.5 Catalent Inc. Latest Developments
11.19 Recipharm AB
11.19.1 Recipharm AB Company Information
11.19.2 Recipharm AB Small Molecule Chemical Drug CDMO Product Offered
11.19.3 Recipharm AB Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Recipharm AB Main Business Overview
11.19.5 Recipharm AB Latest Developments
11.20 Jubilant Pharmova Ltd
11.20.1 Jubilant Pharmova Ltd Company Information
11.20.2 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product Offered
11.20.3 Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Jubilant Pharmova Ltd Main Business Overview
11.20.5 Jubilant Pharmova Ltd Latest Developments
11.21 Patheon Inc. (Thermo Fisher Scientific Inc.)
11.21.1 Patheon Inc. (Thermo Fisher Scientific Inc.) Company Information
11.21.2 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product Offered
11.21.3 Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Patheon Inc. (Thermo Fisher Scientific Inc.) Main Business Overview
11.21.5 Patheon Inc. (Thermo Fisher Scientific Inc.) Latest Developments
11.22 Boehringer Ingelheim Group
11.22.1 Boehringer Ingelheim Group Company Information
11.22.2 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product Offered
11.22.3 Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 Boehringer Ingelheim Group Main Business Overview
11.22.5 Boehringer Ingelheim Group Latest Developments
11.23 Pfizer CentreSource
11.23.1 Pfizer CentreSource Company Information
11.23.2 Pfizer CentreSource Small Molecule Chemical Drug CDMO Product Offered
11.23.3 Pfizer CentreSource Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Pfizer CentreSource Main Business Overview
11.23.5 Pfizer CentreSource Latest Developments
11.24 Baxter International Inc.
11.24.1 Baxter International Inc. Company Information
11.24.2 Baxter International Inc. Small Molecule Chemical Drug CDMO Product Offered
11.24.3 Baxter International Inc. Small Molecule Chemical Drug CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Baxter International Inc. Main Business Overview
11.24.5 Baxter International Inc. Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Small Molecule Chemical Drug CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Small Molecule Chemical Drug CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Human Medicine
Table 4. Major Players of Veterinary Medicine
Table 5. Small Molecule Chemical Drug CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Small Molecule Chemical Drug CDMO Market Size Market Share by Type (2021-2026)
Table 8. Small Molecule Chemical Drug CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Small Molecule Chemical Drug CDMO Market Size Market Share by Application (2021-2026)
Table 11. Global Small Molecule Chemical Drug CDMO Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Player (2021-2026)
Table 13. Small Molecule Chemical Drug CDMO Key Players Head office and Products Offered
Table 14. Small Molecule Chemical Drug CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Small Molecule Chemical Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Small Molecule Chemical Drug CDMO Market Size Market Share by Region (2021-2026)
Table 19. Global Small Molecule Chemical Drug CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Small Molecule Chemical Drug CDMO Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Small Molecule Chemical Drug CDMO Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Small Molecule Chemical Drug CDMO Market Size Market Share by Country (2021-2026)
Table 23. Americas Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Small Molecule Chemical Drug CDMO Market Size Market Share by Type (2021-2026)
Table 25. Americas Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Small Molecule Chemical Drug CDMO Market Size Market Share by Application (2021-2026)
Table 27. APAC Small Molecule Chemical Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Small Molecule Chemical Drug CDMO Market Size Market Share by Region (2021-2026)
Table 29. APAC Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Small Molecule Chemical Drug CDMO Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Small Molecule Chemical Drug CDMO Market Size Market Share by Country (2021-2026)
Table 33. Europe Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Small Molecule Chemical Drug CDMO Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Small Molecule Chemical Drug CDMO
Table 39. Key Market Challenges & Risks of Small Molecule Chemical Drug CDMO
Table 40. Key Industry Trends of Small Molecule Chemical Drug CDMO
Table 41. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Small Molecule Chemical Drug CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Small Molecule Chemical Drug CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Haixiang Pharmaceutical Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 46. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
Table 47. Haixiang Pharmaceutical Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Haixiang Pharmaceutical Main Business
Table 49. Haixiang Pharmaceutical Latest Developments
Table 50. Innovent Biologics Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 51. Innovent Biologics Small Molecule Chemical Drug CDMO Product Offered
Table 52. Innovent Biologics Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Innovent Biologics Main Business
Table 54. Innovent Biologics Latest Developments
Table 55. Betta Pharmaceuticals Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 56. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Product Offered
Table 57. Betta Pharmaceuticals Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Betta Pharmaceuticals Main Business
Table 59. Betta Pharmaceuticals Latest Developments
Table 60. Jiuzhou Pharmaceutical Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 61. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
Table 62. Jiuzhou Pharmaceutical Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Jiuzhou Pharmaceutical Main Business
Table 64. Jiuzhou Pharmaceutical Latest Developments
Table 65. Puluo Pharmaceutical Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 66. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
Table 67. Puluo Pharmaceutical Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Puluo Pharmaceutical Main Business
Table 69. Puluo Pharmaceutical Latest Developments
Table 70. Menohua Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 71. Menohua Small Molecule Chemical Drug CDMO Product Offered
Table 72. Menohua Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Menohua Main Business
Table 74. Menohua Latest Developments
Table 75. Tianyu shares Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 76. Tianyu shares Small Molecule Chemical Drug CDMO Product Offered
Table 77. Tianyu shares Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Tianyu shares Main Business
Table 79. Tianyu shares Latest Developments
Table 80. Aoxiang Pharmaceutical Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 81. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Product Offered
Table 82. Aoxiang Pharmaceutical Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Aoxiang Pharmaceutical Main Business
Table 84. Aoxiang Pharmaceutical Latest Developments
Table 85. Hetero Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 86. Hetero Small Molecule Chemical Drug CDMO Product Offered
Table 87. Hetero Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Hetero Main Business
Table 89. Hetero Latest Developments
Table 90. CellMark Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 91. CellMark Small Molecule Chemical Drug CDMO Product Offered
Table 92. CellMark Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. CellMark Main Business
Table 94. CellMark Latest Developments
Table 95. R&D Systems Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 96. R&D Systems Small Molecule Chemical Drug CDMO Product Offered
Table 97. R&D Systems Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. R&D Systems Main Business
Table 99. R&D Systems Latest Developments
Table 100. Porton Pharmaceuticals Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 101. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Product Offered
Table 102. Porton Pharmaceuticals Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Porton Pharmaceuticals Main Business
Table 104. Porton Pharmaceuticals Latest Developments
Table 105. Kai Laiying Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 106. Kai Laiying Small Molecule Chemical Drug CDMO Product Offered
Table 107. Kai Laiying Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Kai Laiying Main Business
Table 109. Kai Laiying Latest Developments
Table 110. Smart Life Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 111. Smart Life Small Molecule Chemical Drug CDMO Product Offered
Table 112. Smart Life Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Smart Life Main Business
Table 114. Smart Life Latest Developments
Table 115. Notai Biotech Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 116. Notai Biotech Small Molecule Chemical Drug CDMO Product Offered
Table 117. Notai Biotech Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Notai Biotech Main Business
Table 119. Notai Biotech Latest Developments
Table 120. Aurobindo Pharma Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 121. Aurobindo Pharma Small Molecule Chemical Drug CDMO Product Offered
Table 122. Aurobindo Pharma Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Aurobindo Pharma Main Business
Table 124. Aurobindo Pharma Latest Developments
Table 125. Lonza Group Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 126. Lonza Group Small Molecule Chemical Drug CDMO Product Offered
Table 127. Lonza Group Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Lonza Group Main Business
Table 129. Lonza Group Latest Developments
Table 130. Catalent Inc. Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 131. Catalent Inc. Small Molecule Chemical Drug CDMO Product Offered
Table 132. Catalent Inc. Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Catalent Inc. Main Business
Table 134. Catalent Inc. Latest Developments
Table 135. Recipharm AB Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 136. Recipharm AB Small Molecule Chemical Drug CDMO Product Offered
Table 137. Recipharm AB Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Recipharm AB Main Business
Table 139. Recipharm AB Latest Developments
Table 140. Jubilant Pharmova Ltd Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 141. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Product Offered
Table 142. Jubilant Pharmova Ltd Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Jubilant Pharmova Ltd Main Business
Table 144. Jubilant Pharmova Ltd Latest Developments
Table 145. Patheon Inc. (Thermo Fisher Scientific Inc.) Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 146. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Product Offered
Table 147. Patheon Inc. (Thermo Fisher Scientific Inc.) Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Patheon Inc. (Thermo Fisher Scientific Inc.) Main Business
Table 149. Patheon Inc. (Thermo Fisher Scientific Inc.) Latest Developments
Table 150. Boehringer Ingelheim Group Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 151. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Product Offered
Table 152. Boehringer Ingelheim Group Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. Boehringer Ingelheim Group Main Business
Table 154. Boehringer Ingelheim Group Latest Developments
Table 155. Pfizer CentreSource Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 156. Pfizer CentreSource Small Molecule Chemical Drug CDMO Product Offered
Table 157. Pfizer CentreSource Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Pfizer CentreSource Main Business
Table 159. Pfizer CentreSource Latest Developments
Table 160. Baxter International Inc. Details, Company Type, Small Molecule Chemical Drug CDMO Area Served and Its Competitors
Table 161. Baxter International Inc. Small Molecule Chemical Drug CDMO Product Offered
Table 162. Baxter International Inc. Small Molecule Chemical Drug CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Baxter International Inc. Main Business
Table 164. Baxter International Inc. Latest Developments
ポリプロピレンの日本市場（～2031年） The polypropylene (PP) sector in Japan stands as a complex and valuable part of the polymer market, with yearly usage greatly influenced by the country’s key electronics, automotive, and precision manufacturing industries. Unlike other areas where PP is used mainly for general packaging, in Japan, t…- 空港インフラの日本市場（～2031年） Japan’s airport infrastructure is highly developed, reflecting the country’s advanced technology adoption, strict regulatory standards, and high passenger expectations. Key international hubs such as Tokyo Haneda, Tokyo Narita, Kansai International, and Chubu Centrair handle millions of passengers a…
- ファクタリングサービスの日本市場（～2031年） Japan’s factoring market has evolved gradually, shaped by its corporate culture, conservative banking sector, and long-standing trade finance traditions. Historically, Japanese firms have favored internal financing and bank overdraft facilities over third-party receivables financing, leading to slow…
- 会計ソフトウェアの日本市場（～2031年） In Japan, accounting systems are widely adopted across industries, reflecting the operational and reporting requirements of large corporations and smaller companies, with different organizations tailoring systems to meet their specific financial workflows. Large corporations typically deploy compreh…
- 水力発電の日本市場（2026年～2034年） Japan hydropower market size reached 90.9 TWh in 2025. Looking forward, IMARC Group expects the market to reach 115.2 TWh by 2034, exhibiting a growth rate (CAGR) of 2.66% during 2026-2034. The increasing advancements in various technologies, such as integration with the industrial internet of thing…